Identification of computationally designed skeletal and cardiac promoters with high specificity across AAV delivery routes
Abstract Background Precise control of transgene expression is essential for safe and effective AAV gene therapies. While capsid engineering has advanced tissue targeting, progress in developing regulatory elements that confine expression to specific tissues has lagged. This gap limits the ability t...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2026-03-01
|
| Colección: | BMC Biotechnology |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12896-026-01141-1 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
